Clinical Trial Update: Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating almorexant (ACT-078573) for chronic primary insomnia in elderly subjects; the study is completed and results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Almorexant (ACT 078573)

Snippet

Sponsor: Midnight Pharma, LLC | Conditions: Chronic Primary Insomnia | Phase 2 | Status: COMPLETED | Results posted: 2013-03-11